Jean-Marc Roch

Title: The Innovations of Jean-Marc Roch

Introduction

Jean-Marc Roch is a notable inventor based in Salt Lake City, Utah. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patents. His work focuses on understanding the protein-protein interactions that play a crucial role in the pathogenesis of diseases such as Alzheimer's.

Latest Patents

Jean-Marc Roch holds a patent titled "Nucleic acid encoding a phosphatase 2C that interacts with Fe 65." This invention relates to the discovery of protein-protein interactions involved in neurodegenerative disorders. The patent addresses the diagnosis of these disorders, including the identification of predispositions and the existence of the disease. It also encompasses drug screening for agents that can modulate these protein interactions and the identification of additional proteins in the related pathways.

Career Highlights

Jean-Marc Roch is associated with Myriad Genetics, Inc., a company known for its focus on genetic testing and personalized medicine. His work at Myriad Genetics has allowed him to contribute to advancements in understanding complex biological interactions and their implications for health.

Collaborations

Throughout his career, Jean-Marc Roch has collaborated with esteemed colleagues such as Paul L Bartel and Karen A Heichman. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Jean-Marc Roch's innovative work in the field of neurodegenerative disorders highlights the importance of understanding protein interactions in disease mechanisms. His contributions through patents and collaborations continue to pave the way for advancements in medical research and treatment options.